Format
Sort by

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 27

1.

A 18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over aging.

Costes N, Merlet I, Ostrowsky K, Faillenot I, Lavenne F, Zimmer L, Ryvlin P, Le Bars D.

J Nucl Med. 2005 Dec;46(12):1980-9.

2.

Effect of increased serotonin levels on [18F]MPPF binding in rat brain: fenfluramine vs the combination of citalopram and ketanserin.

Udo de Haes JI, Cremers TI, Bosker FJ, Postema F, Tiemersma-Wegman TD, den Boer JA.

Neuropsychopharmacology. 2005 Sep;30(9):1624-31.

3.

Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor-treated depression: an [(18)F] MPPF positron emission tomography study.

Praschak-Rieder N, Hussey D, Wilson AA, Carella A, Lee M, Dunn E, Willeit M, Bagby RM, Houle S, Meyer JH.

Biol Psychiatry. 2004 Oct 15;56(8):587-91.

PMID:
15476688
4.

Occupancy of agonist drugs at the 5-HT1A receptor.

Bantick RA, Rabiner EA, Hirani E, de Vries MH, Hume SP, Grasby PM.

Neuropsychopharmacology. 2004 May;29(5):847-59.

5.

5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study.

Merlet I, Ostrowsky K, Costes N, Ryvlin P, Isnard J, Faillenot I, Lavenne F, Dufournel D, Le Bars D, Mauguière F.

Brain. 2004 Apr;127(Pt 4):900-13.

PMID:
14985263
6.

A reduced extracellular serotonin level increases the 5-HT1A PET ligand 18F-MPPF binding in the rat hippocampus.

Zimmer L, Rbah L, Giacomelli F, Le Bars D, Renaud B.

J Nucl Med. 2003 Sep;44(9):1495-501.

7.
8.

Brain uptake of the acid metabolites of F-18-labeled WAY 100635 analogs.

Carson RE, Wu Y, Lang L, Ma Y, Der MG, Herscovitch P, Eckelman WC.

J Cereb Blood Flow Metab. 2003 Feb;23(2):249-60.

PMID:
12571456
10.

5-HT(1A) receptor imaging in the human brain: effect of tryptophan depletion and infusion on [(18)F]MPPF binding.

Udo de Haes JI, Bosker FJ, Van Waarde A, Pruim J, Willemsen AT, Vaalburg W, Den Boer JA.

Synapse. 2002 Nov;46(2):108-15.

PMID:
12211089
11.

The potential of the beta-Microprobe, an intracerebral radiosensitive probe, to monitor the [(18)F]MPPF binding in the rat dorsal raphe nucleus.

Zimmer L, Pain F, Mauger G, Plenevaux A, Le Bars D, Mastrippolito R, Pujol JF, Renaud B, Lanièce P.

Eur J Nucl Med Mol Imaging. 2002 Sep;29(9):1237-47.

PMID:
12192569
12.

Modeling [18 F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection.

Costes N, Merlet I, Zimmer L, Lavenne F, Cinotti L, Delforge J, Luxen A, Pujol JF, Le Bars D.

J Cereb Blood Flow Metab. 2002 Jun;22(6):753-65.

PMID:
12045674
13.
14.

Quantification of 5-HT(1A) receptors in human brain using p-MPPF kinetic modelling and PET.

Sanabria-Bohórquez SM, Biver F, Damhaut P, Wikler D, Veraart C, Goldman S.

Eur J Nucl Med Mol Imaging. 2002 Jan;29(1):76-81.

PMID:
11807610
15.

Visualisation of serotonin-1A (5-HT1A) receptors in the central nervous system.

Passchier J, van Waarde A.

Eur J Nucl Med. 2001 Jan;28(1):113-29. Review.

PMID:
11202445
16.

In vivo delineation of 5-HT1A receptors in human brain with [18F]MPPF.

Passchier J, van Waarde A, Pieterman RM, Elsinga PH, Pruim J, Hendrikse HN, Willemsen AT, Vaalburg W.

J Nucl Med. 2000 Nov;41(11):1830-5.

17.

Influence of P-glycoprotein on brain uptake of [18F]MPPF in rats.

Passchier J, van Waarde A, Doze P, Elsinga PH, Vaalburg W.

Eur J Pharmacol. 2000 Nov 3;407(3):273-80.

PMID:
11068023
18.

Quantitative imaging of 5-HT(1A) receptor binding in healthy volunteers with [(18)f]p-MPPF.

Passchier J, van Waarde A, Pieterman RM, Elsinga PH, Pruim J, Hendrikse HN, Willemsen AT, Vaalburg W.

Nucl Med Biol. 2000 Jul;27(5):473-6.

PMID:
10962253
19.

Fluoro analogs of WAY-100635 with varying pharmacokinetics properties.

Lang L, Jagoda E, Schmall B, Sassaman M, Ma Y, Eckelman WC.

Nucl Med Biol. 2000 Jul;27(5):457-62. Review.

PMID:
10962250
Items per page

Supplemental Content

Support Center